Read current and past publications from members of our team!
Interested in how the Sleepy Brain Lab is funded? Click to view a full summary from over the years.
Major Goals: Our proposal is designed to probe temporal relationships between delirium and well-characterized EEG signatures that predict cognitive dysfunction. Future preoperative stratification for delirium vulnerability could inform patients and their families regarding the likelihood of potential cognitive trajectories after elective procedures.
Major Goals: This investigation is aimed at determining whether EEG slow waves can be potentiated through CLAS during dexmedetomidine sedation. Furthermore, we will assess whether the intervention of dexmedetomidine and CLAS is associated with quantitative EEG metrics that suggest fulfillment of homeostatic needs. Finally, we will assess whether dexmedetomidine-induced EEG slow waves localize to similar brain structures in the presence and absence of CLAS.
Major Goals: Double-blind, randomized, prospective inpatient trial comparing inhaled nitrous oxide (N2O) vs. placebo paired with treatment as usual in acutely suicidal patients.
Major Goals: Late life treatment-resistant depression (LL-TRD) in older adults is a leading cause of disability, excess mortality from suicide, and dementia. Our mechanistic project, Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) Trial: A Pilot Study, is designed to evaluate the safety and feasibility of serial propofol infusions to promote slow wave sleep in older adults with depression.
McDonnell Grant – Kafashan
Major Goals: Our primary goals are to first: characterize relationships between sleep SWA pre- and post-ECT. Secondly assess the effect of ECT on sleep spindle density. Lastly to quantify the effect of ECT-induced central-positive complexes (CPCs) on sleep spindles and SWA.
Major Goals: Treatment resistant depression (TRD) in older adults is a leading cause of disability, dementia, and poor quality of life. Disrupted slow wave sleep is at the nexus of depression and cognitive dysfunction in older adults, but novel treatments have not targeted this core pathophysiology. These combined Phase 1 and Phase 2 mechanistic clinical trials will investigate whether propofol confers slow wave sleep enhancement, resulting in longer-term improvements to sleep structure, cognitive function, and mood.
In collaboration with Dr. Eric Lenze.